These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25079138)

  • 1. Evaluating uncertainty to strengthen epidemiologic data for use in human health risk assessments.
    Burns CJ; Wright JM; Pierson JB; Bateson TF; Burstyn I; Goldstein DA; Klaunig JE; Luben TJ; Mihlan G; Ritter L; Schnatter AR; Symons JM; Yi KD
    Environ Health Perspect; 2014 Nov; 122(11):1160-5. PubMed ID: 25079138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference in cumulative risk assessment: The roles of directed acyclic graphs.
    Brewer LE; Wright JM; Rice G; Neas L; Teuschler L
    Environ Int; 2017 May; 102():30-41. PubMed ID: 27988137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose reconstruction for the million worker study: status and guidelines.
    Bouville A; Toohey RE; Boice JD; Beck HL; Dauer LT; Eckerman KF; Hagemeyer D; Leggett RW; Mumma MT; Napier B; Pryor KH; Rosenstein M; Schauer DA; Sherbini S; Stram DO; Thompson JL; Till JE; Yoder C; Zeitlin C
    Health Phys; 2015 Feb; 108(2):206-20. PubMed ID: 25551504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal evidence in health decision making: methodological approaches of causal inference and health decision science.
    Kühne F; Schomaker M; Stojkov I; Jahn B; Conrads-Frank A; Siebert S; Sroczynski G; Puntscher S; Schmid D; Schnell-Inderst P; Siebert U
    Ger Med Sci; 2022; 20():Doc12. PubMed ID: 36742460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of exposure reconstruction in occupational human health risk assessment: current methods and a recommended framework.
    Sahmel J; Devlin K; Paustenbach D; Hollins D; Gaffney S
    Crit Rev Toxicol; 2010 Oct; 40(9):799-843. PubMed ID: 20722488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thinking one step ahead: strategies to strengthen epidemiological data for use in risk assessment.
    Arnold C
    Environ Health Perspect; 2014 Nov; 122(11):A311. PubMed ID: 25361211
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of biomonitoring data in exposure and human health risk assessments.
    Albertini R; Bird M; Doerrer N; Needham L; Robison S; Sheldon L; Zenick H
    Environ Health Perspect; 2006 Nov; 114(11):1755-62. PubMed ID: 17107864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Bias Assessments and Evidence Syntheses for Observational Epidemiologic Studies of Environmental and Occupational Exposures: Strengths and Limitations.
    Steenland K; Schubauer-Berigan MK; Vermeulen R; Lunn RM; Straif K; Zahm S; Stewart P; Arroyave WD; Mehta SS; Pearce N
    Environ Health Perspect; 2020 Sep; 128(9):95002. PubMed ID: 32924579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EPA's human exposure research program for assessing cumulative risk in communities.
    Zartarian VG; Schultz BD
    J Expo Sci Environ Epidemiol; 2010 Jun; 20(4):351-8. PubMed ID: 19367326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panel discussion review: session three--issues involved in interpretation of epidemiologic analyses--statistical modeling.
    Bateson TF; Coull BA; Hubbell B; Ito K; Jerrett M; Lumley T; Thomas D; Vedal S; Ross M
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 2():S90-6. PubMed ID: 18079770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.
    Sander M; Cadet J; Casciano DA; Galloway SM; Marnett LJ; Novak RF; Pettit SD; Preston RJ; Skare JA; Williams GM; Van Houten B; Gollapudi BB
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):1-20. PubMed ID: 16164957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology: a foundation of environmental decision making.
    Deener KCK; Sacks JD; Kirrane EF; Glenn BS; Gwinn MR; Bateson TF; Burke TA
    J Expo Sci Environ Epidemiol; 2018 Nov; 28(6):515-521. PubMed ID: 30185947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing systemic problems with exposure assessments to protect the public's health.
    Vandenberg LN; Rayasam SDG; Axelrad DA; Bennett DH; Brown P; Carignan CC; Chartres N; Diamond ML; Joglekar R; Shamasunder B; Shrader-Frechette K; Subra WA; Zarker K; Woodruff TJ
    Environ Health; 2023 Jan; 21(Suppl 1):121. PubMed ID: 36635700
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.